medigraphic.com
ISSN 2225-4676 (Electronic)

2013, Number 2

<< Back Next >>

Rev Cubana Neurol Neurocir 2013; 3 (2)

Presentation and evolution of 26 patients with spinal ependymoma treated with microsurgery in Neurology and Neurosurgery Institute (Cuba)

Fuentes RN, Loureiro RJL, Quintanal CNE, de Arriba RMU, Rodríguez PNJ, de la Paz RM

Language: Spanish
References: 33
Page: 145-155
PDF size: 1185.80 Kb.


ABSTRACT

Objective: To analyze presentation and evolution of 26 adult’s patients with spinal ependymoma assisted in Neurology and Neurosurgery Institute (La Habana, Cuba).
Methods: A study of 26 patients with diagnosis of spinal ependymomas treated with microsurgical methods. Parameters such as clinical presentation and long time before diagnostic, radiographs characteristic, surgical resection strategy, postoperative results and prognostic factors were examined.
Results: The age of patients was between 30 and 65 years, with 61.5 % between 41–50 years. Sensitivity disorders was the first symptoms and more persistent in admission in 21 patients (80.7 %). The majority of ependymomas occur in the filum terminal, conus and caudal equine region. The radical extirpation of the tumor was achieved in 22 patients. In only 2 cases there is evidence of recurrent and improves the outcome with radiation therapy. At a follow–up time, more than 80 % patients (20 cases) were functioning at a grade 1 of the McCormick Scale.
Conclusions: The early diagnosis and the radical surgery of the tumor are decisive factors for minimum or null neurology morbidity.


REFERENCES

  1. Villano JL, Parker CK, Dolecek TA. Descriptive epidemiology of ependymal tumours in the United States. Br J Cancer. 2013;108(11):2367–71.

  2. Miller DC. Surgical pathology of intramedullary spinal cord neoplasms. J. Neurooncol. 2000;47:189–94.

  3. Tarapore PE, Naujokas A, Amin B, Tihan T, Parsa AT, Ames CP, et al. Pathology of spinal ependymomas: An institutional experience over 25 years in 134 patients. Neurosurgery. 2013 May 10. [Epub ahead of print]

  4. Chandy MJ, Babu S. Management of intramedullary spinal cord tumours: review of 68 patients. Neurol India. 2004;47:224–28.

  5. Ogden AT, Wetjen N, Francavilla JL. Intramedullary spinal cord tumours. [Internet]. [citado 24.10.2008]. Disponible en: http://emedicine.medscape.com/article/251133– overview

  6. Greenwood J. Intramedullary tumours of the spinal cord. A follow–up study after total surgical removal. J Neurosurgery. 1963;20:665.

  7. Greenwood J. Surgical removal of intramedullary tumours. J Neurosurgery. 1967;26:276–82.

  8. McCormick PC, Torres R, Post KD, Stein BM. Intramedullary ependymoma of the spinal cord. J Neurosurgery. 1990;72(4):523–32.

  9. Benzagmout M, Boujraf S, Oulali N, Chbani L, Amarti A, Chakour K, et al. Intradural extramedullary ependymoma: is there constantly a hormonal relationship?. Surg Neurol. 2008;70(5):536–38.

  10. Kinsman MJ, Callahan JD, Hattab EM, Cohen–Gadol AA. Extramedullary spinal ependymoma: a diagnostic challenge and review of the literature. Clin Neurol Neurosurg. 2011;113:661–4.

  11. Bonfield ChM, Amin D, Hamilton RL, Gerszten PC. Extramedullary ependymoma near the conus medullaris with lumbar nerve root attachment: Case report. Neurosurgery. 2011;68:831–4.

  12. Ebert C, von Haken M, Meyer–Puttitz B, et al. Molecular genetic analysis of ependymal tumours. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol. 1999;155:627–32.

  13. Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependimomas. A clinic pathologic and immunocytochemical study of 77 cases. Cancer. 1985;56:883–93.

  14. Radhakrishnan N, Nair NS, et al. Tanycytic ependymoma of filum terminale: A case report. Clin Neurol Neurosurg. 2012;114:169–71.

  15. Shamji MF, Benoit BG, Perry AM, Jansen GH. Giant cell ependymoma of the thoracic spine: Pathology case report. J Neurosurgery. 2009;64(3):566–67.

  16. Adamek D, Dec M, Sobol G, Urbanowicz B, Jaworski M. Giant cell ependymoma: A case report. Clin Neurol Neurosurg. 2008;110:176–81.

  17. Akutsu H, Shibada Y, Okazaki M, Hyodo A, Matsumura A. Intramedullary clear cell ependymoma in the cervical spinal cord: A case report. Neurosurgery. 2000; 47(6):1434–39.

  18. Louis D, Ohgaki H, Wiestler O, Cavenee W. WHO classification of tumours of the Central Nervous System. 4th ed. Lyon: IARC Press; 2007. p. 72–78.

  19. Oh MC, Kim JM, Kaur G, Safaee M, Sun MZ, et al. Prognosis by tumor location in adults with spinal ependymomas. Spine. 2012;12:591.

  20. Schwartz TH, McCormick PC. Intramedullary ependymomas: clinical presentation, surgical treatment strategies and prognosis. J Neurooncol. 2000; 47(3):211– 18.

  21. Patrona A, Harders A, Schmieder K, Scholz M. Intraventricular bleeding and transient hydrocephalus in a patient with hemorrhagic filum terminale ependymoma undergoing anticoagulation therapy with fherprocouman. Clin Neurol Neurosurg. 2010;112:552–57.

  22. Voulgaris S, Alexiou GA, Zigouris A, Fotakopoulos G, Michos E, et al. Spinal ependymomas: prognostic factors and treatment results. J Neurosurg Spine. 2013; 18(3):226–35.

  23. Waldron JJ, Cha S. Radiographic features of intramedullary spinal cord tumours. Neurosurg Clin N Am. 2006;17(1):13–9.

  24. Fuentes RN, Felipe AM, Quintanal NC, Rodríguez NJP, et al. Ependimoma intradural extramedular primario. Rev Cub Med Mil. [revista en la Internet]. 2004 [citado 28.06.2013];33(1): Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S013 8–65572004000100009&lng=es.

  25. Kucia EJ, Bambakidis NC, Chang SW, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas, Part 1: Intramedullary ependymomas. Neurosurgery. 2011;68(ONS suppl 1):ons57–ons63.

  26. Kucia EJ, Manghan PH, Kakarla UK, Bambakidis NC, Spetzler RF. Surgical technique and outcomes in the treatment of spinal cord ependymomas, Part 2: Myxopapillary ependymoma. Neurosurgery. 2011;68(ONS 1):ons90–ons94.

  27. Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, et al. Long–term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. J Cancer Res Ther. 2013;9(1):60–3.

  28. Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, et al. Long–term outcome after resection of intraspinal ependymomas: Report of 86 consecutive cases. Neurosurgery. 2010;67(6):1622–31.

  29. Wahab SH, Simpson JR, Michalski JM, Mansur DB. Long term outcome with post–operative radiation therapy for spinal canal ependymoma. J. Neurooncol. 2007;83(1):85– 9.

  30. Fernandes AJ, Dos Santos MJ, Tedeshi H. Surgical management of intramedullary spinal ependymomas. Arq Neuropsiquiatr. 2009;67(2–A):284–9.

  31. Bagley CA, Wilson S, Kothbaver KF, Bookland MS, Epstein F, Jallo GL. Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev. 2009;32(3):321–4.

  32. Boström A, von Lehe M, Hartmann W, Pietsch T, Feuss M, Boström JP, et al. Surgery for spinal cord ependymomas: Outcome and prognostic factors. Neurosurgery. 2011;63:302–9.

  33. Karikari IO, Nimjee SM, Hodges TR, Cutrell E, Hughes BD, Powers CJ, et al. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: A single–center experience with 102 patients. Neurosurgery. 2011;68:188–97.




2020     |     www.medigraphic.com